National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E

Past Highlights
   
 
Results: 1 -10 of 10         results per page
View Search Criteria | Help With Results
           

1.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III


Treatment


Active


18 and over


Pharmaceutical / Industry


A4061028
NCT00471146


2.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III


Treatment


Active


18 and over


Pharmaceutical / Industry


A4061032
AXIS TRIAL, NCT00678392


3.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase II, Phase I


Treatment


Active


18 and over


Pharmaceutical / Industry


A4061020
NCT00460603


4.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase II, Phase I


Treatment


Active


18 and over


Pharmaceutical / Industry


A4061039
NCT00768755


5.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase II


Treatment


Active


18 and over


Pharmaceutical / Industry


A4061023
NCT00282048


6.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase II


Treatment


Active


18 and over


Pharmaceutical / Industry


A4061027
NCT00389441


7.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase II


Treatment


Active


18 and over


Pharmaceutical / Industry


A4061030
NCT00600821


8.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase II


Treatment


Active


18 and over


Pharmaceutical / Industry


A4061034
NCT00615056


9.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase II


Treatment


Active


18 and over


Pharmaceutical / Industry


A4061038
NCT00735904


10.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase I


Treatment


Active


18 and over


Pharmaceutical / Industry


A4061019
NCT00454649

   
   

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov